Worth Venture Partners, LLC - AVEO PHARMACEUTICALS INC ownership

AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 112 filers reported holding AVEO PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.

Quarter-by-quarter ownership
Worth Venture Partners, LLC ownership history of AVEO PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$2,555,329
-54.7%
170,925
-75.0%
1.51%
-56.3%
Q3 2022$5,638,000
+19.0%
685,026
-4.4%
3.45%
+24.0%
Q2 2022$4,736,000
+20.1%
716,436
+1.6%
2.78%
+52.9%
Q1 2022$3,942,000
+43.7%
705,154
+20.5%
1.82%
+34.0%
Q4 2021$2,744,000
-2.3%
585,168
+28.8%
1.36%
+7.6%
Q3 2021$2,808,000454,3641.26%
Other shareholders
AVEO PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
PATHWAY CAPITAL MANAGEMENT, LP 245,606$3,671,8106.55%
AIGH Capital Management LLC 695,358$10,395,6023.42%
BARDIN HILL MANAGEMENT PARTNERS LP 638,360$9,5442.08%
Kellner Capital, LLC 100,016$1,4951.74%
NEXPOINT ASSET MANAGEMENT, L.P. 1,464,807$21,898,8651.70%
Worth Venture Partners, LLC 170,925$2,555,3291.51%
Birchview Capital, LP 100,000$1,4951.06%
BCK CAPITAL MANAGEMENT LP 68,000$1,016,6001.05%
WATER ISLAND CAPITAL LLC 698,915$10,4490.89%
EHP Funds Inc. 292,043$4,3660.82%
View complete list of AVEO PHARMACEUTICALS INC shareholders